Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-163547
Filing Date
2019-06-03
Accepted
2019-06-03 09:18:24
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d740199ds3.htm S-3 382308
2 EX-1.2 d740199dex12.htm EX-1.2 157509
3 EX-4.4 d740199dex44.htm EX-4.4 295766
4 EX-5.1 d740199dex51.htm EX-5.1 32872
5 EX-23.1 d740199dex231.htm EX-23.1 1784
6 GRAPHIC g740199g0531144241805.jpg GRAPHIC 2570
7 GRAPHIC g740199g0531144241993.jpg GRAPHIC 1716
8 GRAPHIC g740199g29x45.jpg GRAPHIC 112617
9 GRAPHIC g740199g63j15.jpg GRAPHIC 32221
  Complete submission text file 0001193125-19-163547.txt   1077261
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-231893 | Film No.: 19872330
SIC: 2834 Pharmaceutical Preparations